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Helper T  cells  play a  crucial  role in the induction  and  amplification  of humoral 
and  T  cell-mediated  immune  responses  in  man.  For  example,  helper  T  cells  are 
absolutely required  for the  polyclonal immunoglobulin  response triggered  by poke- 
weed mitogen  (PWM)  (1)  as well as for antigen-specific  antibody responses to virus 
(2),  soluble  proteins  (3),  hapten  (4),  and  heterologous  erythrocytes  (5).  Moreover, 
helper T  cells markedly facilitate the in vitro generation of allospecific (6) and altered 
self-reactive  (7)  cytotoxic  T  lymphocytes  (CTL)  from  OKT8 ÷  CTL  precursors. 
Although  help  for B  cells  and  CTL  precursors  is  mediated,  predominantly,  by the 
T4  +,  T8-  T  cell  subset,  it  is  not  established  whether  a  single  helper  T  cell  pool 
regulates both arms of the immune response, or if functionally distinct human helper 
T  cell subpopulations exist. To address this question we have analyzed the immuno- 
regulatory  activities  of several  HLA-DR-l-specific,  alloproliferative,  human  T  cell 
lines  (TCL)  recently established  in our laboratory  (8).  Our results  demonstrate that 
helper TCL which trigger polyclonal antibody production by B cells are distinct from 
those which amplify the generation of allospecific CTL. 
Materials  and Methods 
Isolation and Fractionation of Peripheral Blood Lymphocytes (PBL).  Fresh PBL were isolated from 
healthy  volunteers  by  Ficoll-Hypaque  centrifugation.  T  cells  were  isolated  by  E  rosette 
formation, whereas B cell populations consisted of E rosette-negative cells depleted of contam- 
inating T cells by complement (C)-mediated lysis in the presence of OKT3, a monoclonal anti- 
human T  cell antibody (9). 
Allospecific TCL.  The TCL used in these studies have been described previously (8). Briefly, 
alloreactive T  cells,  generated by co-culture of donor A  (HLA-DR 2,  3)  responder cells and 
donor B (HLA-DR 1, 7) x-irradiated stimulators, were isolated by limiting dilution culture and 
propagated by repetitive  stimulation with  interleukin  2  (IL-2) and  x-irradiated  feeder cells. 
Every 7 d, the TCL cells  were expanded  to a  density of 1 x  105/cc  of final  medium,  and 
supplemented with an equal number of x-irradiated  DR  1  ÷ allogeneic feeder cells  (donor B) 
and  an optimal concentration of IL-2 (8). The final  medium consisted of Iscove's modified 
Dulbecco's medium (Gibco Laboratories, Grand Island, NY), supplemented with 10% fetal calf 
serum, penicillin-streptomycin, and 5 x  10  -6 2-mercaptoethanot (Gibco Laboratories). Partially 
cloned TCL derived from cloning plates seeded at 10 cells per microwell or 1 cell per microwell 
were assigned the prefix 10- or 1-, respectively. 
B Cell Helper Assay.  5 ×  105 B cells were cultured alone or with 5 ×  104 autologous T  cells 
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or TCL cells in 0.5 cc of final medium. After 6 d of incubation at 37°C in a 95% air, 5% CO2 
humid  atmosphere,  cultures  were assayed for polyclonal  B cell  activation  using the  reverse 
hemolytic plaque assay (i0). For each culture, three separate  100-/zl aliquots were assayed and 
the data expressed  as  plaque-forming cells  (PFC)  per culture.  SEM for all  PFC results  were 
<10%. 
CTL Helper Assay.  Each sensitization culture consisted of 12 replicate microwells  (Linbro 
MR-2; Flow Laboratories, Inc., Hamden, CT) containing 2 X  105 responder T  cells and  1 X 
105 x-irradiated  (1,500 rad) stimulator cells suspended in 0.2 cc of final medium. In all studies, 
responder  T  cells  were  autologous  to  the  allospecific  TCL  (i.e., derived  from  donor  A). 
Stimulator populations consisted of fresh autologous (donor A) or DR  1  + allogeneic (donor B) 
PBL, or TCL cells  that  had been cultured  with x-irradiated  donor B feeder cells  for 7 d  as 
described above. As a  negative control, x-irradiated  donor B PBL, which had been cultured 
alone for 7 d, were used as stimulators.  After 6 d, sensitization  cultures were harvested and 
assayed, in triplicate, at the killer to target (K/T) ratios indicated for cytotoxicity against SlCr- 
labeled  targets in a  standard  4-h 51Cr-release assay. Results are presented as percent  lysis + 
SEM. The surface phenotype of the cytotoxic effector cells was determined by C-mediated lysis 
in the presence of ascites,  OKT4, or OKT8 as previously described (7). 
Results 
The allospecific TLC used in these studies have been described previously (8).  Each 
is comprised exclusively of T  cells belonging to the T4 ÷, T8- subset  and proliferates 
specifically to allogeneic stimulator  cells bearing the HLA-DRw  1 antigen.  In addi- 
tion, many of these TCL  (10-31,  10-36,  10-41, and  1-7)  provide major histocompati- 
bility  complex  (MHC)-restricted  help  for B  cell  differentiation.  Thus,  co-culture of 
TCL cells with DRw  1  +, but not DRw 1-, B cells results in a vigorous polyclonal PFC 
response as measured in the reverse hemolytic plaque assay. Although MHC restricted 
at  the  inductive  level,  helper  TCL  cells  that  have  been  activated  by  DRw  1  + 
stimulators  can trigger the differentiation  of "bystander" DRw  1- B cells  (8). 
In contrast,  other DRw  1-specific TCL  (e.g.,  1-8 and  10-33)  did not provide help 
for B cells, suggesting that they may be involved in other aspects ofimmunoregulation. 
We were, therefore, interested to determine if these TCL could provide help for T  cell 
responses and in particular  for the generation of cytotoxic T  cells. To this end, TCL 
cells  that  had  been  "fed"  x-irradiated  DRw  1  + allogenic  cells  7  d  previously  were 
harvested,  washed,  x-irradiated,  and co-cultured  with  freshly isolated  autologous T 
cells.  After  6  d,  the  allospecific  cytotoxic response  generated  in  these  cultures  was 
assayed. This sensitization  protocol was chosen for two reasons.  First, we have shown 
that DRw  1  ÷ feeders provide a  powerful antigen-specific stimulus that activates and 
enhances  the  growth of the  allospecific TCL cells  (8).  Second, after  several  days in 
culture,  x-irradiated  feeder cells  are  poorly immunogenic,  therefore  permitting  any 
helper influence mediated by the TCL cells to be more readily evaluated. 
As shown in Table I, precuhured donor B allogeneic feeders, either alone or in the 
presence  of  1-7  or  10-31  TCL  cells,  are  poor  stimulators  of an  alloreactive  CTL 
response.  In  contrast,  precultured  donor  B  feeders,  in  conjunction  with  1-8  TCL 
cells,  stimulate  a  eytotoxic  response  against  donor  B  targets  that  is  equivalent  to 
that  triggered  by  fresh  allogeneic  stimulators.  The  effector  CTL  generated  in 
these  sensitization  cultures  are  OKT8 +  (Table  II)  and  specific  for  Class  I  MHC 
(HLA-A 23)  determinants  expressed on the allogeneic feeder cells  (Table III). More- 
over, TCL  1-8 cells can enhance the cytotoxic response directed against DRw  1- cells 
present  in the sensitization  culture,  suggesting that  these TCL may act through  the 
elaboration  of nonspecific helper  factor(s)  (data  not  shown).  In summary, TCL  1-8 FRIEDMAN  AND  THOMPSON  BRIEF  DEFINITIVE  REPORT  1677 
TABLE  I 
Amplification of Allospecific Cytotoxicity by TCL  1-8 
Description of culture 
Responder  X-irradiated stimulator 
Percent lysis :t: SEM on targets 
A  B 
K/T, 40:1  K/T, 40:1  K/T,  20:1  K/T,  10:1 
E +  Donor A  --0.5 :t: 0.7  --3.5 ±  1.4  0.1  ±  2.2  NT 
E -~  Donor B  --1.1  ±  0.9  23.1  :t: 1.8  12.7 :t: 1.6  5.7 ±  1.4 
E +  Donor B  feeders  -2.3  ±  1.4  4.4 ±  0.5  2.6 ±  1.1  --0.3 ±  1.7 
E ÷  TCL  1-7 4- Donor B  NT  6.1  ±  2.3  -0.4  :t:  1.3  -2.4  ±  1.2 
feeders 
E +  TCL  1-8 +  Donor B  -1.2  4- 0.4  19.4 ±  0.4  10.9 :t: 2.0  4.9 4- 0.4 
feeders 
E +  TCL  10-31  +  Donor B  NT  1.5 ±  0.2  0.6 ±  0.7  0.1  4- 0.4 
feeders 
Responder  T  cells,  autologous  to the TCL, were co-cultured  with fresh x-irradiated  autologous  (donor  A) or allogeneic 
(donor B) PBL, x-irradiated allogeneic PBL feeders precultured  alone for 7 d  (donor B feeders) or TCL cells that had been 
precultured  for 7 d  with x-irradiated  B  feeders. TCL stimulators  were x-irradiated  before use as stimulators.  After 6  d, 
cytotoxicity on 51Cr-labeled  PBL targets was measured at the K/T  ratios indicated.  NT, not tested. 
TABLE  II 
Cytotoxic Effector Cells are OKT8 + 
Percent lysis ±  SEM of B  targets 
Treatment  of killer 
cells  K/T  ratio 
40:1  20:1  10:1  5:1 
Ascites +  C  45.9 ±  4.5  37.1  ±  4.9  22.6 4- 3.2  11.2  4-  1.2 
OKT  4  4- C  50.4 ±  4.2  44.5 ±  1.4  30.3 ±  0.4  16.9 ±  7.1 
OKT8  4- C  7.1  ±  2.2  2.4 ±  1.3  2.6 4- 0.8  0.2 -+ 0.8 
Responder T  cells were co-cultured  with x-irradiated  1-8 TCL cells that had been precuhured  for 
7  d  with  B  feeders.  After 6  d,  the culture  was harvested,  divided into  three  groups and  treated 
with a  1:250 dilution  of ascites, OKT4, or OKT8  in the presence of C. Each  group was washed, 
counted,  and assayed at the K/T  ratio indicated  for cytotoxicity on 51 Cr-laheled  B target ceils. 
TABLE  III 
CTL Induced by TCL  1-8 are Specific for Class I MHC Determinants 
Percent  lysis 4- SEM on targets 
Target  Target cell HLA type 
cell  K/T ratio 
donor 
A  B  DRw  40:1  20:1  10:1 
Experiment  1 
Experiment  2 
A  2,3  12,35  2,3  3.1  ±  1.2  NT  0.8 4- 0.3 
B  3,23  i2,21  1,7  56.9 _+ 6.3  NT  27.1  ±  2.2 
C  1,2  8,w44  3,5  3.9 ~  1.4  NT  2.2 ±  0.5 
D  23,26  14,w44  ,7  24.1  ±  3.7  NT  9.3 ±  1.6 
E  3,w33  27,w35  1,5  2.6 ±  0.8  NT  1.4 _+ 0.2 
B  3,23  12,21  1,7  56.5 _+ 3.5  34.7 4- 2.2  20.0 _+ 2.4 
F  26,29  I6,35  4,5  9.2 +_ 3.1  5.8 4-  1.4  0.6 +  0.3 
G  23,26  16~21  4,7  49.4  4- 3.7  30.4 -4-  1.6  13.5  __. 2.6 
Responder T  cells were co-cultured with x-irradiated  1-8 TCL cells that had been precultured  for 7 d  with B feeders. After 
6  d, the culture  was harvested and assayed at  the K/T  ratios indicated  for cytotoxicity on a  panel of 5~Cr-labeled  target 
cells of known HLA haplotype.  NT, not tested. 
cells appear to provide a "second signal" for CTL precursors that have been partially 
activated by interaction with antigen. 
It is striking that TCL 1-8, which amplifies allospecific CTL responses, is minimally 
active in  the B  cell helper assay,  while TCL  1-7 and  10-31,  which provide potent 1678  FRIEDMAN  AND  THOMPSON  BRIEF  DEFINITIVE  REPORT 
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Fro.  1,  Reciprocating helper activities of allospecific TCL.  Four DRw-l-specific TCL, cultured 
for  7 d  with donor B  feeders, were harvested, washed, and assayed for B  cell- and CTL-directed 
helper  activity.  (Top)  5  ×  10  ~ DRw  1  +  B  ceils  (donor  B)  were  cultured  alone or with  5  ×  104 
autologous T  ceils or  the  various TCL cells.  After 6  d,  cultures were  assayed for  PFC  activity. 
(Bottom)  Responder T  cells, co-cultured with  the following x-irradiated  stimulator populations, 
were assayed for cytotoxicity on 5~Cr-labeled donor B targets: fresh donor B stimulators (O); TCL 
1-8 (ai);  10-33  (0);  10-36 (A);  10-4l  (LX). 
DRw-restricted help for B cells, do not activate CTL precursors. These results suggest 
that allospecific human T  cells may mediate distinct, reciprocating helper activities. 
To pursue this point, we extended our studies to include other DRw-1-specific TCL 
available in our laboratory and assayed simultaneously for B cell- and CTL-directed 
helper activity. As shown  (Fig.  1, top), TCL 10-36  and  10-41,  but not  10-33  or  1-8, 
effectively trigger a polyclonal PFC response by DRw 1  + B cells. In contrast, TCL i0- 
33 and 1-8 markedly enhance the generation of allospecific CTL, whereas TCL 10-36 
and  10-41 do not provide T  cell help (Fig.  1, bottom). 
Discussion 
This report describes the identification of two types of OKT4  ÷, DRw-l-specific, 
alloproliferative human  TCL that  mediate distinct,  reciprocating helper functions. 
One  preferentially triggers the  differentiation of B  cells into  PFC,  while the  other 
selectively amplifies allospecific CTL responses. It is likely that these TCL differ with 
respect to the helper molecules which they elaborate. Thus, after antigen activation, 
the former may produce T  cell replacing factor (TRF) while the latter releases killer 
cell activating factor (KAF). It should be noted that cloned human  (I I) TCL may FRIEDMAN AND THOMPSON  BRIEF DEFINITIVE REPORT  1679 
elaborate a wide spectrum of immunoregulatory molecules, including TRF and KAF. 
One might argue, therefore, that the restricted helper functions mediated by our TCL 
reflect  an  artifact of long-term in  vitro growth  that  has led  to  the selective loss of 
mediator production.  We would point out that  the functional restrictions described 
have been a  stable characteristic  of these TCL since their inception > 1 yr ago  (8). 
Moreover, our findings are consistent with reports describing functional heterogeneity 
within  freshly  isolated  human  helper  T  cell  populations  (12,  13).  For  example, 
Gatenby et al.  (13)  observed that both  Leu 3+,8 ÷ and  Leu 3+,8 -  T  cells proliferate 
during  the autologous  mixed  lymphocyte response,  but  only the  Leu  3+,8 -  T  cells 
provide help for B cell differentiation. It will be of interest to characterize our TCL 
with respect to Leu 8  and other monoclonal antibodies that recognize a  fraction of 
the inducer T  cell population. 
Finally,  these  findings  may be relevant to our understanding  of acquired  immu- 
nodeficiency (AID) syndromes in man. For example, in some patients with common 
variable hypogammaglobulinemia, T  cell-mediated responses are preserved, while in 
the recently described AID syndrome, patients are markedly deficient with respect to 
T  cell function but have normal or heightened humoral immune responses. Interest- 
ingly, both conditions  may be characterized by a  reduced ratio of T4 to T8 cells in 
the  peripheral  blood  (14,  15).  Conceivably,  these  diametrically  opposed  forms  of 
immunodeficiency may result from an acquired defect (e.g., infectious agent) involving 
one of the  helper T  cell  subsets  described  in  this  report,  or  an  immunoregulatory 
circuit specifically targeted to one of these subsets. 
Summary 
Using a panel of partially cloned, OKT4  ÷, DRw-1-specific, alloproliferative human 
T  cell lines, we have identified two functionally restricted and reciprocating types of 
helper  T  cells.  One  provides  major  histocompatibility  complex-restricted  help  for 
plaque-forming cell responses by DRw  1  + allogeneic B cells; the other preferentially 
amplifies the  generation  of allospecific cytotoxic T  lymphocytes (CTL)  from CTL 
precursors that have been suboptimally triggered by alloantigen. 
We wish to thank Dr. Nicole Suciu-Foca for performing the HLA typing of the donors used in 
this study and Dr. Leonard Chess for his encouragement and help throughout all phases of this 
work. 
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